Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FDM08
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,694
Award facts
- Contract value 100% obligated
- $72,693.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $72,693.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 22, 2025, for supply of Jakafi 10 mg tablets (60-count units). The delivery order carries an ultimate completion date of September 23, 2025, and will be performed at the contractor's location in Park Ridge, Illinois. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete openly in federal procurement markets despite its status as a woman-owned small business.
DMS Pharmaceutical Group is a pharmaceutical wholesaler specializing in supplying medications and medical supplies to federal healthcare facilities, particularly Department of Defense installations. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables DLA to issue firm fixed-price orders for a broad portfolio of pharmaceutical products supporting military health facility needs nationwide and globally. Jakafi, a prescription medication used to treat certain blood disorders and myelofibrosis, represents one of the specialized pharmaceutical products available through this comprehensive supply agreement.
Quick answers
Who was awarded contract SPE2DB25FDM08?
SPE2DB25FDM08 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FDM08 worth?
The government has obligated $72,694 on SPE2DB25FDM08.
Is contract SPE2DB25FDM08 an order under another contract?
Yes. SPE2DB25FDM08 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM08 competed?
The extent of competition for SPE2DB25FDM08 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award